(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 4.09% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Icon's revenue in 2026 is $8,102,602,000.On average, 21 Wall Street analysts forecast ICLR's revenue for 2026 to be $630,809,398,252, with the lowest ICLR revenue forecast at $582,320,841,432, and the highest ICLR revenue forecast at $666,698,566,292. On average, 19 Wall Street analysts forecast ICLR's revenue for 2027 to be $659,291,652,888, with the lowest ICLR revenue forecast at $598,661,866,880, and the highest ICLR revenue forecast at $701,671,415,148.
In 2028, ICLR is forecast to generate $702,511,374,400 in revenue, with the lowest revenue forecast at $619,889,927,976 and the highest revenue forecast at $781,162,104,360.